A citation-based method for searching scientific literature

María Gómez-Ruiz, Carmen Rodríguez-Cueto, Eva Luna-Piñel, Mariluz Hernández-Gálvez, Javier Fernández-Ruiz. Front Mol Neurosci 2019
Times Cited: 9







List of co-cited articles
50 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Cannabinoids in Neurodegenerative Disorders and Stroke/Brain Trauma: From Preclinical Models to Clinical Applications.
Javier Fernández-Ruiz, María A Moro, José Martínez-Orgado. Neurotherapeutics 2015
79
44


Molecular and functional interaction between GPR18 and cannabinoid CB2 G-protein-coupled receptors. Relevance in neurodegenerative diseases.
Irene Reyes-Resina, Gemma Navarro, David Aguinaga, Enric I Canela, Clara T Schoeder, Michał Załuski, Katarzyna Kieć-Kononowicz, Carlos A Saura, Christa E Müller, Rafael Franco. Biochem Pharmacol 2018
34
33




Identification and functional characterization of brainstem cannabinoid CB2 receptors.
Marja D Van Sickle, Marnie Duncan, Philip J Kingsley, Abdeslam Mouihate, Paolo Urbani, Ken Mackie, Nephi Stella, Alexandros Makriyannis, Daniele Piomelli, Joseph S Davison,[...]. Science 2005
33

Neuroprotection in Oxidative Stress-Related Neurodegenerative Diseases: Role of Endocannabinoid System Modulation.
Janos Paloczi, Zoltan V Varga, George Hasko, Pal Pacher. Antioxid Redox Signal 2018
52
33

Cannabinoid CB2 receptor: a new target for controlling neural cell survival?
Javier Fernández-Ruiz, Julián Romero, Guillermo Velasco, Rosa M Tolón, José A Ramos, Manuel Guzmán. Trends Pharmacol Sci 2007
278
22

Structure of a cannabinoid receptor and functional expression of the cloned cDNA.
L A Matsuda, S J Lolait, M J Brownstein, A C Young, T I Bonner. Nature 1990
22

The orphan receptor GPR55 is a novel cannabinoid receptor.
E Ryberg, N Larsson, S Sjögren, S Hjorth, N-O Hermansson, J Leonova, T Elebring, K Nilsson, T Drmota, P J Greasley. Br J Pharmacol 2007
22

The endocannabinoid system in cardiovascular function: novel insights and clinical implications.
Salvador Sierra, Natasha Luquin, Judith Navarro-Otano. Clin Auton Res 2018
25
22

Dronabinol oral solution in the management of anorexia and weight loss in AIDS and cancer.
Melissa E Badowski, Paa Kwesi Yanful. Ther Clin Risk Manag 2018
47
22

An update on PPAR activation by cannabinoids.
Saoirse Elizabeth O'Sullivan. Br J Pharmacol 2016
225
22

Crystal Structure of the Human Cannabinoid Receptor CB2.
Xiaoting Li, Tian Hua, Kiran Vemuri, Jo-Hao Ho, Yiran Wu, Lijie Wu, Petr Popov, Othman Benchama, Nikolai Zvonok, K'ara Locke,[...]. Cell 2019
168
22

Cannabinoid CB1 and CB2 Receptor Signaling and Bias.
Mikkel Søes Ibsen, Mark Connor, Michelle Glass. Cannabis Cannabinoid Res 2017
107
22

Cannabinoid Ligands Targeting TRP Channels.
Chanté Muller, Paula Morales, Patricia H Reggio. Front Mol Neurosci 2019
209
22

Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor.
R B Laprairie, A M Bagher, M E M Kelly, E M Denovan-Wright. Br J Pharmacol 2015
501
22


Rimonabant: From RIO to Ban.
Amir H Sam, Victoria Salem, Mohammad A Ghatei. J Obes 2011
118
22


Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors.
R Mechoulam, S Ben-Shabat, L Hanus, M Ligumsky, N E Kaminski, A R Schatz, A Gopher, S Almog, B R Martin, D R Compton. Biochem Pharmacol 1995
22

The CB2 receptor and its role as a regulator of inflammation.
Caroline Turcotte, Marie-Renée Blanchet, Michel Laviolette, Nicolas Flamand. Cell Mol Life Sci 2016
230
22

Monoacylglycerol lipase (MAGL) as a promising therapeutic target.
Ana Gil-Ordóñez, Mar Martín-Fontecha, Silvia Ortega-Gutiérrez, María L López-Rodríguez. Biochem Pharmacol 2018
48
22


CB1 Receptor Signaling in the Brain: Extracting Specificity from Ubiquity.
Arnau Busquets-Garcia, Jaideep Bains, Giovanni Marsicano. Neuropsychopharmacology 2018
146
22

Identification of the First Synthetic Allosteric Modulator of the CB2 Receptors and Evidence of Its Efficacy for Neuropathic Pain Relief.
Francesca Gado, Lorenzo Di Cesare Mannelli, Elena Lucarini, Simone Bertini, Elena Cappelli, Maria Digiacomo, Lesley A Stevenson, Marco Macchia, Tiziano Tuccinardi, Carla Ghelardini,[...]. J Med Chem 2019
29
22

Medical Use of Cannabinoids.
Ana Isabel Fraguas-Sánchez, Ana Isabel Torres-Suárez. Drugs 2018
89
22

Isolation and structure of a brain constituent that binds to the cannabinoid receptor.
W A Devane, L Hanus, A Breuer, R G Pertwee, L A Stevenson, G Griffin, D Gibson, A Mandelbaum, A Etinger, R Mechoulam. Science 1992
22

Cannabinoid type 2 receptors mediate a cell type-specific self-inhibition in cortical neurons.
Alexander Stumpf, Daniel Parthier, Rosanna P Sammons, A Vanessa Stempel, Jörg Breustedt, Benjamin R Rost, Dietmar Schmitz. Neuropharmacology 2018
22
22

Changes in CB(1) and CB(2) receptors in the post-mortem cerebellum of humans affected by spinocerebellar ataxias.
Carmen Rodríguez-Cueto, Cristina Benito, Javier Fernández-Ruiz, Julián Romero, Mariluz Hernández-Gálvez, María Gómez-Ruiz. Br J Pharmacol 2014
39
22

The endocannabinoid system as an emerging target of pharmacotherapy.
Pál Pacher, Sándor Bátkai, George Kunos. Pharmacol Rev 2006
22

HU-308: a specific agonist for CB(2), a peripheral cannabinoid receptor.
L Hanus, A Breuer, S Tchilibon, S Shiloah, D Goldenberg, M Horowitz, R G Pertwee, R A Ross, R Mechoulam, E Fride. Proc Natl Acad Sci U S A 1999
419
22


Endocannabinoid-mediated control of synaptic transmission.
Masanobu Kano, Takako Ohno-Shosaku, Yuki Hashimotodani, Motokazu Uchigashima, Masahiko Watanabe. Physiol Rev 2009
966
22

Potential of the cannabinoid CB(2) receptor as a pharmacological target against inflammation in Parkinson's disease.
Yolanda Gómez-Gálvez, Cristina Palomo-Garo, Javier Fernández-Ruiz, Concepción García. Prog Neuropsychopharmacol Biol Psychiatry 2016
109
22

Benefits of VCE-003.2, a cannabigerol quinone derivative, against inflammation-driven neuronal deterioration in experimental Parkinson's disease: possible involvement of different binding sites at the PPARγ receptor.
Concepción García, María Gómez-Cañas, Sonia Burgaz, Belén Palomares, Yolanda Gómez-Gálvez, Cristina Palomo-Garo, Sara Campo, Joel Ferrer-Hernández, Carolina Pavicic, Carmen Navarrete,[...]. J Neuroinflammation 2018
33
22

GPR55: A therapeutic target for Parkinson's disease?
Marta Celorrio, Estefanía Rojo-Bustamante, Diana Fernández-Suárez, Elena Sáez, Ander Estella-Hermoso de Mendoza, Christa E Müller, María J Ramírez, Julen Oyarzábal, Rafael Franco, María S Aymerich. Neuropharmacology 2017
47
22

Heteromerization of GPR55 and cannabinoid CB2 receptors modulates signalling.
N A Balenga, E Martínez-Pinilla, J Kargl, R Schröder, M Peinhaupt, W Platzer, Z Bálint, M Zamarbide, I G Dopeso-Reyes, A Ricobaraza,[...]. Br J Pharmacol 2014
83
22

VCE-003.2, a novel cannabigerol derivative, enhances neuronal progenitor cell survival and alleviates symptomatology in murine models of Huntington's disease.
Javier Díaz-Alonso, Juan Paraíso-Luna, Carmen Navarrete, Carmen Del Río, Irene Cantarero, Belén Palomares, José Aguareles, Javier Fernández-Ruiz, María Luz Bellido, Federica Pollastro,[...]. Sci Rep 2016
39
22

Receptor-heteromer mediated regulation of endocannabinoid signaling in activated microglia. Role of CB1 and CB2 receptors and relevance for Alzheimer's disease and levodopa-induced dyskinesia.
Gemma Navarro, Dasiel Borroto-Escuela, Edgar Angelats, Íñigo Etayo, Irene Reyes-Resina, Marta Pulido-Salgado, Ana I Rodríguez-Pérez, Enric I Canela, Josep Saura, José Luis Lanciego,[...]. Brain Behav Immun 2018
61
22

CB1 and GPR55 receptors are co-expressed and form heteromers in rat and monkey striatum.
E Martínez-Pinilla, I Reyes-Resina, A Oñatibia-Astibia, M Zamarbide, A Ricobaraza, G Navarro, E Moreno, I G Dopeso-Reyes, S Sierra, A J Rico,[...]. Exp Neurol 2014
61
22

Cannabinoid receptors CB1 and CB2 form functional heteromers in brain.
Lucía Callén, Estefanía Moreno, Pedro Barroso-Chinea, David Moreno-Delgado, Antoni Cortés, Josefa Mallol, Vicent Casadó, José Luis Lanciego, Rafael Franco, Carmen Lluis,[...]. J Biol Chem 2012
143
22

Cannabinoid pharmacology/therapeutics in chronic degenerative disorders affecting the central nervous system.
Maria S Aymerich, Ester Aso, Miguel A Abellanas, Rosa M Tolon, Jose A Ramos, Isidre Ferrer, Julian Romero, Javier Fernández-Ruiz. Biochem Pharmacol 2018
52
22

Cannabinoid receptor as a potential therapeutic target for Parkinson's Disease.
Himadri Shekhaar Baul, Ceera Manikandan, Dwaipayan Sen. Brain Res Bull 2019
11
22


Cannabinoids for Medical Use: A Systematic Review and Meta-analysis.
Penny F Whiting, Robert F Wolff, Sohan Deshpande, Marcello Di Nisio, Steven Duffy, Adrian V Hernandez, J Christiaan Keurentjes, Shona Lang, Kate Misso, Steve Ryder,[...]. JAMA 2015
22


The role of the endocannabinoid system in pain.
Stephen G Woodhams, Devi Rani Sagar, James J Burston, Victoria Chapman. Handb Exp Pharmacol 2015
81
22

Targeting Cannabinoid CB2 Receptors in the Central Nervous System. Medicinal Chemistry Approaches with Focus on Neurodegenerative Disorders.
Gemma Navarro, Paula Morales, Carmen Rodríguez-Cueto, Javier Fernández-Ruiz, Nadine Jagerovic, Rafael Franco. Front Neurosci 2016
74
22


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.